KEGG: bmj:BMULJ_02606
STRING: 395019.BMULJ_02606
The sucC gene in B. multivorans encodes the beta subunit of Succinyl-CoA ligase [ADP-forming], a critical enzyme in the tricarboxylic acid (TCA) cycle. Similar to other bacteria, the gene is typically part of an operon structure that includes sucD (encoding the alpha subunit). This organization allows for coordinated expression of both subunits necessary for the formation of the functional heterodimeric enzyme.
In B. multivorans, genome analysis has revealed significant variation between different strains, with large structural genomic variations observed between isolates from different patients . These variations include active roles for transposases and mobile prophage elements, which could potentially affect the genomic context of metabolic genes including sucC . Researchers should note that genomic analysis of clinical isolates shows limited within-patient evolution but high between-patient strain diversity, suggesting that environmental reservoirs maintain microdiverse populations .
For comparative genomic studies of sucC, researchers should:
Use multilocus sequence typing (MLST) to identify strain types
Apply both short and long-read sequencing technologies to accurately map genomic context
Compare sequence conservation across multiple Burkholderia species, particularly B. cenocepacia, which shares many pathogenic features
For optimal expression of recombinant B. multivorans sucC, consider the following methodological approaches:
E. coli-based expression systems:
BL21(DE3) strain is preferred due to its reduced protease activity
pET vector systems with T7 promoter offer high-level expression control
Codon optimization may be necessary as B. multivorans has a different codon usage bias than E. coli
Critical optimization parameters:
Induction temperature: Lower temperatures (16-20°C) often improve protein folding
IPTG concentration: 0.1-0.5 mM is typically sufficient; higher concentrations may lead to inclusion bodies
Media supplementation: Addition of cofactors like magnesium and ATP may enhance proper folding
Co-expression with chaperones: GroEL/GroES can improve yield of correctly folded protein, especially relevant as GroEL has been identified as an immunoreactive protein in B. multivorans
Alternative expression systems:
Pseudomonas-based expression systems may provide a more native-like environment for protein folding
Cell-free protein synthesis systems allow rapid screening of expression conditions without cellular constraints
For functional expression, co-expression with the alpha subunit (sucD) is often necessary, as the active enzyme functions as a heterodimer. Expression timing and stoichiometry between the subunits should be carefully controlled.
A systematic purification approach is essential for maintaining enzyme activity while achieving high purity:
Affinity chromatography options:
His-tagged purification: 6xHis tag at N-terminus is preferred for minimal interference with enzyme activity
GST-fusion: Provides solubility enhancement but may require tag removal for activity assays
Tandem affinity purification: Consider dual tagging (His and Strep) for exceptional purity
Purification buffer optimization:
Include 10-20% glycerol to stabilize the enzyme structure
Maintain pH between 7.4-8.0 (optimum for activity)
Add 1-5 mM DTT or 2-mercaptoethanol to prevent oxidation of cysteine residues
Include 1-2 mM EDTA to remove divalent metal ions that may promote oxidation
Activity preservation steps:
Perform all steps at 4°C
Add protease inhibitors (e.g., PMSF, Complete™) during initial lysis
Include substrate analogs (e.g., 0.5 mM succinate) to stabilize the enzyme
Consider dialysis rather than dilution for buffer exchange to minimize mechanical stress
Critical quality control measures:
Verify purity by SDS-PAGE (expected MW ~41 kDa)
Confirm identity by mass spectrometry
Assess oligomeric state by size exclusion chromatography (functional enzyme should exist as heterodimer with alpha subunit)
Verify activity using coupled enzyme assays
Verification of enzymatic activity requires carefully designed assays that monitor the reversible reaction:
Succinyl-CoA + Pi + ADP ⇌ Succinate + CoA + ATP
Forward reaction (succinyl-CoA to succinate):
Coupled spectrophotometric assay: Link ATP production to NADH oxidation via pyruvate kinase and lactate dehydrogenase
Monitor decrease in absorbance at 340 nm as NADH is oxidized
Reaction mixture includes: succinyl-CoA (0.1-0.5 mM), ADP (1-2 mM), Pi (5-10 mM), MgCl₂ (5 mM), PEP (1 mM), NADH (0.2 mM), pyruvate kinase and lactate dehydrogenase
Luciferase-based ATP detection:
More sensitive than spectrophotometric methods
Allows endpoint or continuous measurement
Compatible with high-throughput screening formats
Reverse reaction (succinate to succinyl-CoA):
Direct measurement of succinyl-CoA formation:
HPLC-based quantification of succinyl-CoA
Reaction mixture includes: succinate (5-10 mM), CoA (0.5-1 mM), ATP (2-5 mM), MgCl₂ (5 mM)
Kinetic analysis:
Determine the following parameters using varied substrate concentrations:
Km for succinyl-CoA, ADP, Pi (forward reaction)
Km for succinate, CoA, ATP (reverse reaction)
Vmax in both directions
Effect of pH (optimal typically 7.4-8.0)
Effect of temperature (optimal typically 30-37°C)
It's worth noting that mammalian SCS isoforms show tissue-specific preferences for either ATP or GTP . When characterizing B. multivorans sucC, confirm its specificity for ADP/ATP rather than GDP/GTP with proper controls.
The sucC gene product plays a pivotal role in B. multivorans metabolism during infection:
Central metabolic functions:
TCA cycle operation: Catalyzes the only substrate-level phosphorylation step in the cycle, generating ATP
Carbon flux regulation: Controls the balance between catabolic and anabolic pathways
Metabolic adaptation: Likely involved in bacterial adaptation to the nutrient-limited CF lung environment
Infection-specific metabolic adaptations:
Genomic analysis of clinical isolates reveals that B. multivorans undergoes limited within-patient evolution but shows high between-patient strain diversity
Key metabolic genes, potentially including sucC, may be targets for parallel adaptations across multiple patients, indicating that strain-specific genomic backgrounds may dictate adaptation routes within the CF lung
The microaerobic environment in CF lungs may shift metabolic flux through the TCA cycle, potentially altering the role of sucC
Research methodologies to investigate:
Comparative transcriptomics: RNA-seq comparing expression in laboratory media versus CF sputum samples
Metabolic flux analysis: 13C-labeling to track carbon flow through central metabolism during infection
Proteomics: Quantitative analysis of sucC expression levels in clinical isolates
Knockout studies: Creation of sucC mutants to assess effects on growth and virulence
| Metabolic Parameter | Acute Infection | Chronic Adaptation | Relevance to sucC Function |
|---|---|---|---|
| Oxygen availability | Microaerobic | Anaerobic microniches | Affects TCA cycle flux |
| Carbon source | Glucose, amino acids | Amino acids, fatty acids | Changes substrate entry points to TCA |
| Energy demand | High (rapid growth) | Moderate (persistence) | Alters requirement for ATP generation |
| Stress response | Oxidative stress defense | Biofilm formation | May involve metabolic reprogramming |
| Antimicrobial resistance | Intrinsic mechanisms | Adaptive mechanisms | May involve energy-dependent efflux |
Both B. multivorans and B. cenocepacia are clinically relevant species within the Burkholderia cepacia complex, but with distinct patterns of virulence and metabolism:
Comparative expression patterns:
Immunoproteomic analysis has identified multiple proteins that are differentially expressed between these species during human infection
While 15 proteins were found to be immunogenic across both species, 14 immunoreactive proteins were exclusive to B. cenocepacia strains, and 15 were exclusive to B. multivorans
Key metabolic enzymes, including elongation factor-Tu, were identified as immunoreactive across all strains examined
Methodological approaches to investigate differences:
Comparative transcriptomics:
RNA-seq analysis of both species under identical conditions
qRT-PCR validation of differential expression
Ribosome profiling to assess translational efficiency
Proteomic comparison:
2D-PAGE coupled with mass spectrometry
SILAC labeling for quantitative comparison
Analysis of post-translational modifications
Functional genomics:
Creation of isogenic mutants in both species
Complementation studies with cross-species genes
Competition assays to determine fitness effects
Pathogenicity implications:
Differences in central metabolism may contribute to the distinct infection patterns observed between these species
Metabolic adaptation may influence persistence in different host niches
Energy production through sucC activity could support virulence factor expression and antibiotic resistance mechanisms
Resolving contradictory findings requires systematic approaches that address experimental variables and biological complexity:
Standardization of experimental systems:
Strain characterization:
Infection model standardization:
Clearly defined in vitro cell culture conditions (cell types, passage number, media composition)
Standardized animal models with defined genetic backgrounds
Consideration of alternative models (e.g., Galleria mellonella, ex vivo lung tissue)
Resolution of mechanistic contradictions:
Genetic approaches:
Clean deletion mutants with complementation controls
Conditional expression systems to control timing and level of expression
Site-directed mutagenesis to separate catalytic from structural roles
Biochemical verification:
In vitro enzyme assays to confirm activity differences
Metabolomic profiling to identify downstream effects
Flux analysis to determine metabolic consequences
Addressing biological complexity:
Host-pathogen interaction studies:
Transcriptional response analysis of both host and pathogen
Single-cell studies to address population heterogeneity
Temporal analysis to capture dynamic interactions
Environmental factor assessment:
Oxygen tension effects on metabolism and virulence
Nutrient availability influence on metabolic pathway utilization
pH and other physiochemical parameters
| Contradiction Type | Potential Causes | Resolution Methods | Expected Outcomes |
|---|---|---|---|
| Strain-dependent differences | Genetic background, mutations | Whole genome sequencing, complementation | Identification of strain-specific effects |
| Model-dependent differences | Host factors, experimental conditions | Standardized protocols, multiple models | Understanding of context-dependent roles |
| Technique-dependent differences | Sensitivity, specificity issues | Method validation, orthogonal approaches | Robust, reproducible findings |
| Temporal discrepancies | Growth phase, adaptation | Time-course studies, inducible systems | Dynamic understanding of sucC function |
| Direct vs. indirect effects | Metabolic network complexity | Targeted mutations, metabolomics | Clear delineation of causal relationships |
Succinyl-CoA synthetase exists in forms specific for either ATP/ADP or GTP/GDP, with the specificity determined by the β-subunit (encoded by sucC in the case of the ADP-forming enzyme) :
Structural determinants of nucleotide specificity:
β-subunit nucleotide-binding domain:
ATP grasp domain located near the N-terminus of the β-subunit
Specific amino acid residues within this domain create hydrogen bonding patterns that favor adenine over guanine
Critical residues:
Experimental approaches to investigate specificity:
Homology modeling:
Generate structural models based on known crystal structures
Identify putative specificity-determining residues
Site-directed mutagenesis:
Create point mutations at predicted specificity-determining residues
Assess changes in nucleotide preference through activity assays
Protein crystallography:
Obtain crystal structures with bound nucleotides
Compare binding site architecture with GDP-specific variants
Molecular dynamics simulations:
Model nucleotide binding and release
Calculate binding energies for different nucleotides
In mammals, ATP-specific SCS is typically found in tissues involved in catabolic metabolism (brain, heart, muscle), while GTP-specific SCS is found in anabolic tissues (liver, kidney) . The functional significance of ADP specificity in B. multivorans may relate to its metabolic adaptations during infection.
Isotope labeling combined with metabolic flux analysis provides powerful insights into carbon flow through central metabolism:
Experimental design for flux analysis:
Selection of labeled substrates:
[1-13C]glucose: Differentiates pentose phosphate pathway from glycolysis
[U-13C]glucose: Comprehensive labeling pattern across central metabolism
[1,2-13C]acetate: Directly traces TCA cycle flux
[U-13C]glutamate: Probes anaplerotic reactions
Culture conditions:
Defined minimal media with labeled substrate as sole carbon source
Steady-state growth to achieve isotopic equilibrium
Physiologically relevant conditions (oxygen limitation, pH, etc.)
Analytical methods:
Metabolite extraction and derivatization:
Rapid quenching to prevent metabolic changes
Acid extraction for polar metabolites
Chemical derivatization for GC-MS analysis
Mass spectrometry analysis:
GC-MS for primary metabolites
LC-MS/MS for coenzyme A derivatives including succinyl-CoA
High-resolution MS for accurate isotopologue distribution
NMR spectroscopy:
Provides positional isotopic enrichment information
Complements MS data for flux model validation
Flux calculation and modeling:
Metabolic network reconstruction:
Genome-based pathway mapping
Integration of experimental evidence for active pathways
Incorporation of biomass requirements
Computational flux estimation:
13C-FLUX or similar software for flux calculation
Sensitivity analysis to identify key parameters
Statistical evaluation of flux solutions
Applications to sucC function:
Wild-type vs. sucC mutant comparison:
Identify metabolic rerouting in response to altered TCA cycle function
Quantify energetic consequences of sucC modulation
Infection-relevant conditions:
Compare flux distributions under aerobic vs. microaerobic conditions
Assess carbon source preferences during simulated infection
Antibiotic response:
Evaluate metabolic adaptation to antibiotic stress
Identify potential metabolic vulnerabilities
While specific crystallization conditions for B. multivorans sucC are not widely reported, the following approaches have proven successful for related enzymes:
Protein preparation for crystallization:
Homogeneity optimization:
Size exclusion chromatography as final purification step
Dynamic light scattering to confirm monodispersity
Thermal shift assays to identify stabilizing buffer conditions
Complex formation:
Co-purification or reconstitution with alpha subunit (sucD product)
Addition of substrates, products, or stable analogs
Consideration of ternary complexes with nucleotides
Crystallization screening:
Initial condition identification:
Commercial sparse matrix screens (Hampton, Molecular Dimensions, Qiagen)
Sitting drop vapor diffusion at 4°C and 18°C
Microseeding from initial crystals
Optimization strategies:
Fine grid screens around promising conditions
Additive screens to improve crystal quality
Streak seeding for crystal quality improvement
Data collection considerations:
Cryoprotection optimization:
Glycerol, ethylene glycol, or PEG 400 supplementation
Flash cooling in liquid nitrogen
Room temperature data collection for sensitive crystals
Synchrotron data collection:
High-brilliance beamlines for microcrystals
Strategy optimization for maximum completeness
Multiple datasets for radiation-sensitive crystals
Alternative structural approaches:
Cryo-electron microscopy:
Single-particle analysis for high-resolution structure
Particularly valuable for capturing different conformational states
Small-angle X-ray scattering (SAXS):
Solution-based structural analysis
Information on conformational changes upon substrate binding
Hydrogen-deuterium exchange mass spectrometry:
Maps protein dynamics and ligand interactions
Complements static crystal structures
For B. multivorans sucC, researchers should note that conformational changes are likely critical for function, as catalytic histidine residues must move approximately 35 Å during the catalytic cycle to facilitate phosphoryl transfer .
The relationship between sucC function and virulence requires careful investigation using multiple approaches:
Genetic manipulation strategies:
Mutant construction:
Clean deletion mutants using allelic exchange
Point mutations to alter catalytic activity without structural disruption
Conditional expression systems for essential genes
Complementation analysis:
Wild-type gene restoration
Cross-complementation with orthologs from related species
Site-directed mutants with varying levels of activity
Virulence phenotype assessment:
In vitro models:
Adhesion to respiratory epithelial cells
Invasion efficiency
Intracellular survival
Biofilm formation capacity
Ex vivo models:
Survival in CF sputum samples
Interaction with primary CF airway epithelial cells
Response to host defense mechanisms
In vivo models:
Appropriate animal models (considering limitations)
Bacterial burden quantification
Inflammatory response assessment
Survival analysis
Fitness evaluation:
Competition assays:
Mixed infections with wild-type and mutant strains
Calculation of competitive index
Long-term evolution experiments
Stress resistance:
Oxidative stress tolerance
Antibiotic susceptibility
Nutrient limitation survival
| Mutation Type | Expected Metabolic Effect | Predicted Virulence Impact | Experimental Approaches |
|---|---|---|---|
| Null mutation | TCA cycle disruption | Severe attenuation if viable | Growth curves, metabolomics |
| Catalytic site mutation | Reduced enzyme efficiency | Fitness cost in nutrient-limited conditions | Enzyme assays, competition studies |
| Regulatory region mutation | Altered expression levels | Context-dependent effects | qRT-PCR, reporter constructs |
| Nucleotide specificity mutation | Altered energy currency balance | Subtle fitness effects | Flux analysis, long-term evolution |
Genomic analysis of clinical isolates suggests that B. multivorans undergoes specific adaptations during CF infection, with a set of 30 parallel adaptations identified across multiple patients . Investigating whether sucC is among these adaptation targets could provide insights into its role in virulence.
The interconnected nature of central metabolism creates significant challenges for isolating the specific contributions of sucC:
Network complexity challenges:
Pathway redundancy:
Alternative routes for carbon flux around blocked steps
Anaplerotic reactions that can bypass certain TCA cycle steps
Compensatory regulation of other enzymes
Pleiotropic effects:
Changes in redox balance affecting multiple pathways
Altered energy charge influencing numerous cellular processes
Accumulation of metabolites with regulatory functions
Experimental approaches to address challenges:
Genetic strategies:
Construction of conditional mutants for targeted expression control
Tunable promoter systems to create varying levels of expression
Double mutants to block compensatory pathways
Systems biology approaches:
Multi-omics integration (transcriptomics, proteomics, metabolomics)
Computational modeling of metabolic networks
Time-resolved sampling to capture dynamic responses
Biochemical approaches:
In vitro reconstitution of connected reactions
Isotope dilution experiments to quantify flux through specific steps
Metabolite profiling with stable isotope tracing
Analytical considerations:
Metabolite measurements:
Rapid sampling to capture true metabolic state
Appropriate extraction methods for different metabolite classes
Absolute quantification rather than relative abundance
Enzyme activity assays:
Development of specific assays for individual enzymes
Consideration of in vivo vs. in vitro activity differences
Analysis of regulatory modifications
Data integration:
Correlation analysis across multiple datasets
Machine learning approaches for pattern recognition
Bayesian network analysis for causality inference
CRISPR-Cas9 systems offer powerful tools for precise genetic manipulation of B. multivorans:
CRISPR system optimization:
Vector system selection:
All-in-one vectors vs. dual-plasmid systems
Inducible Cas9 expression to reduce toxicity
Temperature-sensitive replicons for plasmid curing
sgRNA design:
Multiple sgRNA testing for optimal targeting
Avoidance of potential off-target sites
Assessment of PAM site accessibility in Burkholderia genomes
Delivery methods:
Electroporation conditions optimized for Burkholderia
Conjugation-based transfer from E. coli donors
Consideration of restriction barriers
Editing strategies for sucC functional analysis:
Knockout approaches:
Complete gene deletion using homology-directed repair
Frame-shift mutations for gene inactivation
Premature stop codon introduction
Point mutation introduction:
Catalytic site mutations to alter activity
Nucleotide specificity determinant alterations
Regulatory site modifications
Regulatory element manipulation:
Promoter replacements for controlled expression
Introduction of degradation tags for protein turnover control
Ribosome binding site modifications for translation efficiency
Validation and phenotyping:
Genetic verification:
Sanger sequencing of modified regions
Whole genome sequencing to detect off-target effects
RT-PCR to confirm expression changes
Functional confirmation:
Enzyme activity assays
Metabolite profiling
Growth phenotype characterization
Advanced phenotyping:
Virulence factor expression
Biofilm formation capacity
Antibiotic susceptibility profiles
| Parameter | Options to Test | Success Indicators | Troubleshooting Approaches |
|---|---|---|---|
| Cas9 source | S. pyogenes, S. aureus, other variants | Editing efficiency, toxicity | Codon optimization, inducible expression |
| sgRNA design | Multiple target sites, various lengths | Cleavage efficiency in vitro | Alternative PAM sites, modified sgRNAs |
| Homology arm length | 500 bp, 750 bp, 1000 bp | HDR efficiency | Increase length, optimize GC content |
| Selection strategy | Antibiotic markers, counterselection | Clean mutant isolation | Alternative markers, FACS-based selection |
| Editing verification | PCR, Sanger, NGS | Accurate sequence confirmation | Deep sequencing, phenotypic validation |
Evolutionary analysis of sucC provides insights into its functional importance and adaptation:
Comparative genomic approaches:
Sequence conservation analysis:
Multiple sequence alignment across Burkholderia species
Identification of highly conserved residues
Calculation of selection pressure (dN/dS ratios)
Structural conservation mapping:
Projection of conservation scores onto structural models
Identification of conserved functional domains
Analysis of species-specific variations
Synteny analysis:
Examination of gene neighborhood conservation
Identification of co-evolved gene clusters
Detection of genomic rearrangements affecting sucC
Functional implications assessment:
Conservation patterns:
Catalytic residues typically show highest conservation
Species-specific variations may indicate adaptation
Lineage-specific insertions/deletions may relate to specific niches
Selection analysis:
Positive selection suggests adaptive evolution
Negative selection indicates functional constraints
Neutral evolution suggests functional redundancy
Co-evolution networks:
Identification of proteins that co-evolve with sucC
Inference of functional interactions
Detection of compensatory mutations
Experimental validation:
Cross-species complementation:
Testing functional conservation through heterologous expression
Identification of species-specific functional differences
Domain swapping to map functional regions
Ancestral sequence reconstruction:
Resurrection of predicted ancestral enzymes
Comparison of kinetic properties
Analysis of specificity evolution
Multilocus sequence typing (MLST) analysis has identified globally distributed B. multivorans sequence types associated with human infection , providing a framework for understanding strain diversity and evolution. Combining this population structure information with specific analysis of sucC could reveal patterns of adaptation related to metabolic function.
The cystic fibrosis lung presents a complex, often microaerobic environment that influences bacterial metabolism:
Oxygen-responsive regulation:
Transcriptional regulation:
Identification of oxygen-responsive promoter elements
Analysis of transcription factor binding sites
Characterization of regulatory networks
Post-transcriptional control:
mRNA stability under varying oxygen conditions
sRNA-mediated regulation
Translational efficiency changes
Experimental approaches:
Controlled oxygen environments:
Continuous culture systems with defined oxygen tension
Microfluidic devices with oxygen gradients
Anaerobic chambers with controlled oxygen exposure
Gene expression analysis:
qRT-PCR for targeted gene expression analysis
RNA-seq for genome-wide transcriptional response
Proteomics to confirm translation of transcriptional changes
Enzyme activity measurements:
In vitro activity assays under varying oxygen levels
In vivo activity inference through metabolite ratios
Structural analysis of oxygen-dependent modifications
Infection-relevant models:
Artificial sputum medium:
Mimics CF lung environment
Can be prepared with varying oxygen levels
Allows for controlled experimental manipulation
Biofilm models:
Natural oxygen gradients form within biofilms
Spatial transcriptomics to map expression patterns
Confocal microscopy with oxygen-sensitive probes
Ex vivo and in vivo systems:
CF lung tissue explants
Animal models with tissue oxygen measurements
Clinical sample analysis when available
| Oxygen Level | Expected TCA Cycle Function | Predicted sucC Role | Alternative Pathways |
|---|---|---|---|
| Aerobic | Full cycle operation | ATP generation | Limited alternative needs |
| Microaerobic | Partial cycle operation | Balanced anabolic/catabolic functions | Enhanced anaplerotic reactions |
| Anaerobic | Branched operation | Primarily biosynthetic | Fermentation pathways active |